Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contact sensitivity to topical corticosteroids.

J D Guin

    Journal of the American Academy of Dermatology
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Contact sensitivity to topical corticosteroids can cause chronic eczema and dermatitis. Patch testing is crucial for identifying allergens and guiding treatment by switching to non-reactive steroid formulations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Baby-wipe dermatitis: preservative-induced hand eczema in parents and persons using moist towelettes.

    American journal of contact dermatitis : official journal of the American Contact Dermatitis Society·2001
    Same author

    Contact urticaria from benzyl alcohol presenting as intolerance to saline soaks.

    Contact dermatitis·2001
    Same author

    Rosemary cheilitis: one to remember.

    Contact dermatitis·2001
    Same author

    Allergic contact cheilitis from di-isostearyl malate in lipstick.

    Contact dermatitis·2001
    Same author

    Treatment of toxicodendron dermatitis (poison ivy and poison oak).

    Skin therapy letter·2001
    Same author

    Sensitivity to adipic acid used in polyester synthesis.

    Contact dermatitis·2001
    Same journal

    Real-world experience with extended deucravacitinib-biologic combination therapy in refractory psoriasis and psoriatic arthritis.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Response to Kvist-Hansen et al. 'Baseline monocytes ≥925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.'

    Journal of the American Academy of Dermatology·2026
    Same journal

    Navigating Difficult Conversations: Contraceptive Communication with Transgender and Gender Diverse Patients Starting Isotretinoin.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Ultrasound-Guided Hyaluronidase Administration with Remote Expert Guidance for Vascular Adverse Events after Filler Treatment.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Adalimumab Biosimilars and Access Barriers in Dermatology.

    Journal of the American Academy of Dermatology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Allergology
    • Pharmacology

    Background:

    • Topical corticosteroids are widely used for inflammatory skin conditions.
    • Contact sensitivity to these agents can lead to therapeutic failure and diagnostic challenges.

    Observation:

    • Five cases of contact sensitivity to topical corticosteroids are detailed.
    • Patients presented with chronic hand eczema or dermatitis unresponsive to treatment.
    • Allergies ranged from single corticosteroid (amcinonide) to multiple agents, with some cross-reactivity noted.

    Findings:

    • Sensitivity levels varied from mild to severe.
    • Two patients also showed sensitivity to ethylenediamine.
    • Cross-reactions between corticosteroids are common but require patch test confirmation.

    Related Experiment Videos

    Implications:

    • Identifying specific corticosteroid allergens is vital for managing non-responsive dermatoses.
    • Patch testing provides a reliable method for diagnosing contact sensitivity.
    • Treatment involves allergen avoidance and substitution with non-reactive topical steroids.